BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22690831)

  • 1. Thymic neuroendocrine tumour in multiple endocrine neoplasia type 1: female patients are not rare exceptions.
    Sakurai A; Imai T; Kikumori T; Horiuchi K; Okamoto T; Uchino S; Kosugi S; Suzuki S; Suyama K; Yamazaki M; Sato A;
    Clin Endocrinol (Oxf); 2013 Feb; 78(2):248-54. PubMed ID: 22690831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: A single-centre study, systematic review and meta-analysis.
    Ye L; Wang W; Ospina NS; Jiang L; Christakis I; Lu J; Zhou Y; Zhu W; Cao Y; Wang S; Perrier ND; Young WF; Ning G; Wang W
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):706-716. PubMed ID: 28940393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel association of thymic carcinoid with a germline mutation in a kindred with multiple endocrine neoplasia 1 (MEN1).
    Khoo J; Bee YM; Giraud S; Chen RY; Rajasoorya C; Teh BT
    Exp Clin Endocrinol Diabetes; 2012 May; 120(5):257-60. PubMed ID: 22549346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines).
    Goudet P; Murat A; Cardot-Bauters C; Emy P; Baudin E; du Boullay Choplin H; Chapuis Y; Kraimps JL; Sadoul JL; Tabarin A; Vergès B; Carnaille B; Niccoli-Sire P; Costa A; Calender A;
    World J Surg; 2009 Jun; 33(6):1197-207. PubMed ID: 19294466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database.
    Sakurai A; Suzuki S; Kosugi S; Okamoto T; Uchino S; Miya A; Imai T; Kaji H; Komoto I; Miura D; Yamada M; Uruno T; Horiuchi K; Miyauchi A; Imamura M; ; Fukushima T; Hanazaki K; Hirakawa S; Igarashi T; Iwatani T; Kammori M; Katabami T; Katai M; Kikumori T; Kiribayashi K; Koizumi S; Midorikawa S; Miyabe R; Munekage T; Ozawa A; Shimizu K; Sugitani I; Takeyama H; Yamazaki M
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):533-9. PubMed ID: 21950691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
    Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal treatment of sporadic and inherited neuroendocrine tumors of the thymus.
    Habbe N; Waldmann J; Bartsch DK; Fendrich V; Rothmund M; Langer P
    Surgery; 2008 Nov; 144(5):780-5. PubMed ID: 19081021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic carcinoid in multiple endocrine neoplasia 1: genotype-phenotype correlation and prevention.
    Lim LC; Tan MH; Eng C; Teh BT; Rajasoorya RC
    J Intern Med; 2006 Apr; 259(4):428-32. PubMed ID: 16594911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No Association of Blood Type O With Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
    Nell S; van Leeuwaarde RS; Pieterman CR; de Laat JM; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IH; Vriens MR; Valk GD
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3850-5. PubMed ID: 26247473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patients.
    de Laat JM; Pieterman CR; van den Broek MF; Twisk JW; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Vriens MR; Valk GD
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3325-33. PubMed ID: 24915123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Various neuroendocrine tumors in a family with multiple endocrine neoplasia type 1].
    Sepp K; Valkusz Z
    Orv Hetil; 2013 Dec; 154(51):2037-42. PubMed ID: 24334135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroendocrine neoplasms of the mediastinum].
    Brcic L; Heidinger M; Popper H
    Pathologe; 2016 Sep; 37(5):434-40. PubMed ID: 27507161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.
    Machens A; Schaaf L; Karges W; Frank-Raue K; Bartsch DK; Rothmund M; Schneyer U; Goretzki P; Raue F; Dralle H
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):613-22. PubMed ID: 17590169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymic carcinoids in multiple endocrine neoplasia type 1.
    Teh BT; Zedenius J; Kytölä S; Skogseid B; Trotter J; Choplin H; Twigg S; Farnebo F; Giraud S; Cameron D; Robinson B; Calender A; Larsson C; Salmela P
    Ann Surg; 1998 Jul; 228(1):99-105. PubMed ID: 9671073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of the neuroendocrine phenotype in thymus neoplasms].
    Ferolla P; Urbani M; Ascani S; Puma F; Ribacchi R; Battista Bolis G; Santeusanio F; Daddi G; Angeletti G; Avenia N
    Chir Ital; 2002; 54(3):351-4. PubMed ID: 12192931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
    Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical genetics of neuroendocrine tumors].
    Karges W; Adler G
    Med Klin (Munich); 2003 Dec; 98(12):712-6. PubMed ID: 14685672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors.
    Baudin E; Bidart JM; Rougier P; Lazar V; Ruffié P; Ropers J; Ducreux M; Troalen F; Sabourin JC; Comoy E; Lasser P; DeBaere T; Schlumberger M
    J Clin Endocrinol Metab; 1999 Jan; 84(1):69-75. PubMed ID: 9920064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and prognostic implications of the genetic diagnosis of hereditary NET syndromes in asymptomatic patients.
    Ramundo V; Milone F; Severino R; Savastano S; Di Somma C; Vuolo L; De Luca L; Lombardi G; Colao A; Faggiano A
    Horm Metab Res; 2011 Oct; 43(11):794-800. PubMed ID: 22009375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p.L105Vfs mutation in a family with thymic neuroendocrine tumor combined with MEN1: a case report.
    Zheng H; Zhou S; Tang W; Wang Q; Zhang X; Jin X; Yuan Y; Fu J
    BMC Neurol; 2020 Mar; 20(1):76. PubMed ID: 32126984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.